Gara Jalqabaatti › Rhabdomyosarcoma
Qorannoo klinikaalii Rhabdomyosarcoma Ameerikaa Keessatti hirmaatuu
Qorannoo 26 Rhabdomyosarcoma f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.
Magaalota qorannoo baay'ee qaban
- Houston, TXQorannoo 6
- Memphis, TNQorannoo 6
- Washington, DCQorannoo 5
- Salt Lake City, UTQorannoo 4
- Philadelphia, PAQorannoo 4
- Boston, MAQorannoo 4
- Seattle, WAQorannoo 3
- Birmingham, ALQorannoo 3
- Dallas, TXQorannoo 3
- Baltimore, MDQorannoo 3
- The Bronx, NYQorannoo 3
- Aurora, COQorannoo 3
Naannoon
- AlabamaQorannoo 3
- CaliforniaQorannoo 7
- ColoradoQorannoo 3
- Distaarikii KoloombiyaaQorannoo 4
- FloridaQorannoo 3
- MarylandQorannoo 4
- MassachusettsQorannoo 4
- New YorkQorannoo 4
- OhioQorannoo 5
- PennsylvaniaQorannoo 5
- TennesseeQorannoo 8
- TexasQorannoo 9
- UtahQorannoo 4
- WashingtonQorannoo 3
Qorannoo yeroo dhihootti haaromfaman
Takkalaa qorannoo (Ingiliffa)
FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 3 hanga 39 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT06865664Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
Namoota walitti qabaa jiraSadarkaa 1
24 Months – 18 Years · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06441331Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
Hanga umuriin 30 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT06541262A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Namoota walitti qabaa jiraSadarkaa 3
Hanga umuriin 50 · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT07466316Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
Namoota walitti qabaa jira
Umuriin hundi · Saalaa hunda · Haaromfame 21-Hag-2026 · NCT07514819Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 23 · Saalaa hunda · Haaromfame 13-Hag-2026 · NCT07172958Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT04715191Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT05210374Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Ado-2026 · NCT07628634PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 1 hanga 30 · Saalaa hunda · Haaromfame 22-Ado-2026 · NCT06721689Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma
Namoota walitti qabaa jira
Hanga umuriin 39 · Saalaa hunda · Haaromfame 13-Ado-2026 · NCT06796543Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
6 Months – 25 Years · Saalaa hunda · Haaromfame 30-Wax-2026 · NCT06625190Familial Investigations of Childhood Cancer Predisposition
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 17-Wax-2026 · NCT03050268Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease
Namoota walitti qabaa jiraSadarkaa 2
Hanga umuriin 22 · Saalaa hunda · Haaromfame 15-Wax-2026 · NCT06023641VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
6 Months – 30 Years · Saalaa hunda · Haaromfame 02-Wax-2026 · NCT04796012B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Namoota walitti qabaa jiraSadarkaa 1
Hanga umuriin 21 · Saalaa hunda · Haaromfame 19-Cam-2026 · NCT04897321Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Namoota walitti qabaa jiraSadarkaa 1/2
12 Months – 30 Years · Saalaa hunda · Haaromfame 19-Cam-2026 · NCT04901702Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 30 · Saalaa hunda · Haaromfame 15-Elb-2026 · NCT04308330Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 1 hanga 50 · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT01804634Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 hanga 49 · Saalaa hunda · Haaromfame 19-Gur-2026 · NCT06709495Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 26 · Saalaa hunda · Haaromfame 17-Gur-2026 · NCT07148050HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 1 hanga 25 · Saalaa hunda · Haaromfame 22-Ama-2026 · NCT04995003Molecular Analysis Of Solid Tumors
Namoota walitti qabaa jiraQorannoo ilaalaa
Hanga umuriin 25 · Saalaa hunda · Haaromfame 12-Sad-2025 · NCT01050296Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
Namoota walitti qabaa jiraSadarkaa 1
Hanga umuriin 21 · Saalaa hunda · Haaromfame 03-Sad-2025 · NCT06198296Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
7 Months – 21 Years · Saalaa hunda · Haaromfame 16-Onk-2025 · NCT02508038Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.